Lancashire and South Cumbria
Formulary
Formulary
6 Endocrine system
06-07-02 Drugs affecting gonadotrophins
| Linzagolix |
|
Formulary
|
Moderate to severe symptoms of uterine fibroids. |
 NICE TA996: Linzagolix for treating moderate to severe symptoms of uterine fibroids |
|
| Relugolix–estradiol–norethisterone acetate Ryeqo® |
|
Formulary
|
Tablets : Estradiol (as Estradiol hemihydrate) 1 mg, Norethisterone acetate 500 microgram, Relugolix 40 mg |
|
NICE TA832: Relugolix–estradiol–norethisterone acetate for treating moderate to severe symptoms of uterine fibroids |
|
|
Links
LSCMMG: Trans Female Gender Dysphoria Information Sheet- LSCMMG: Trans Male Gender Dysphoria Information Sheet
- LSCMMG: Triptorelin NMR
- NICE HST21: Setmelanotide for treating obesity caused by LEPR or POMC deficiency
- NICE HST31: Setmelanotide for treating obesity and hyperphagia in Bardet-Biedl syndrome
- NICE TA832: Relugolix–estradiol–norethisterone acetate for treating moderate to severe symptoms of uterine fibroids
- NICE TA996: Linzagolix for treating moderate to severe symptoms of uterine fibroids